[1]
N. Purwitasari, M. Agil, S. Siswodihardjo, S. Maulana, and M. S. Zubair, “The activity of bioactive compounds from bidara upas (Merremia mammosa (Lour) Hall. f.) as an inhibitor of SARS-CoV2 entry stage: In silico study”, Pharm Educ, vol. 23, no. 4, pp. p. 340–343, Oct. 2023.